Interaction between human pancreatic elastase and plasma protease inhibitors

Area of Science:

• Biochemistry
• Proteomics

Background:

• Human pancreatic elastase is a key protease involved in various physiological and pathological processes.
• Serum contains major elastase inhibitors, primarily alpha 1-antitrypsin (AAT) and alpha 2-macroglobulin (A2M).
• Understanding the interaction dynamics between elastase and its inhibitors is crucial for comprehending protease regulation.

Purpose of the Study:

• To investigate the preferential binding of human pancreatic elastase by serum inhibitors.
• To characterize the properties and molar ratios of elastase-inhibitor complexes.
• To determine the enzymatic activity of elastase when bound to different inhibitors.

Main Methods:

• Agarose gel electrophoresis to analyze the migration of elastase-inhibitor complexes.
• Immunoprecipitation using antibodies against elastase and inhibitors.
• Enzyme activity assays using low molecular weight substrates.

Main Results:

• Human serum inhibits elastase primarily through complexation with AAT and A2M.
• Elastase preferentially binds to A2M in serum.
• Elastase-AAT and elastase-A2M complexes migrate as alpha 2-globulins.
• Elastase bound to AAT is enzymatically inactive, whereas elastase bound to A2M retains activity.
• Molar combining ratios were determined as 1:1 for elastase:AAT and 2:1 for elastase:A2M.

Conclusions:

• A2M plays a significant role in elastase neutralization in serum, binding it preferentially and maintaining some enzymatic activity.
• AAT effectively inactivates elastase upon binding, contributing to protease control.
• The differential binding and activity retention provide insights into the distinct roles of AAT and A2M in regulating elastase function.